United States

Safety concerns warrant rigorous scrutinywhen it comes to the selection, clearance andregistration of pharmaceutical trademarks. Tomarket a new pharmaceutical product in theUnited States, a US adopted name – a genericnon-proprietary name – must first be obtained.Existing US adopted name stems describing thesubstance, its action or use should be employed.The non-proprietary name is also reviewedby the international non-proprietary nameprogramme of the World Health Organisationto ensure international harmonisation.